Aristotle Capital Boston’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-193,064
Closed -$17M 124
2017
Q3
$17M Buy
193,064
+18,000
+10% +$1.58M 1.52% 13
2017
Q2
$15.2M Buy
175,064
+28,541
+19% +$2.13M 1.7% 9
2017
Q1
$9.25M Sell
146,523
-47,801
-25% -$3.16M 1.23% 29
2016
Q4
$12.8M Buy
194,324
+30,082
+18% +$1.89M 1.75% 7
2016
Q3
$11.4M Buy
164,242
+7,472
+5% +$504K 2.03% 4
2016
Q2
$9.86M Buy
156,770
+5,298
+3% +$328K 1.91% 6
2016
Q1
$9.5M Buy
151,472
+5,596
+4% +$345K 1.9% 5
2015
Q4
$9.94M Buy
145,876
+23,583
+19% +$1.53M 2.02% 4
2015
Q3
$7.57M Sell
122,293
-3,171
-3% -$213K 1.85% 8
2015
Q2
$8.07M Buy
125,464
+15,938
+15% +$1.07M 1.84% 7
2015
Q1
$7.56M Buy
109,526
+37,829
+53% +$2.41M 2.35% 1
2014
Q4
$3.98M Buy
+71,697
New +$4.14M 1.99% 4

Other funds holding PRXL

Aristotle Capital Boston's PRXL Position: Q4 2017 in Review

Aristotle Capital Boston sold out of Parexel International Corp (PRXL) in Q4 2017, closing a stake of 193,064 shares — an estimated $17M sold.

Aristotle Capital Boston first reported a position in PRXL in Q4 2014 and held it in 12 quarters. The position peaked at $17M in Q3 2017. 1 fund tracked by Wall St. Rank holds PRXL as of Q4 2017.

  • Aristotle Capital Boston reported no remaining Parexel International Corp position as of Q4 2017 after selling out during the quarter.
  • Aristotle Capital Boston sold 193,064 Parexel International Corp shares in Q4 2017, an estimated $17M.
  • Aristotle Capital Boston first reported a position in Parexel International Corp in Q4 2014 and held it in 12 quarters.
  • Aristotle Capital Boston's Parexel International Corp position peaked at $17M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Parexel International Corp as of Q4 2017.

Based on Aristotle Capital Boston's 13F filing for Q4 2017, filed 14 Feb 2018.